Combining the Multi-Targeted Tyrosine Kinase Inhibitor Vandetanib with the Anti-Estrogen Fulvestrant Enhances its Anti-tumor Effect in Non-Small Cell Lung Cancer

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 7; no. 3; pp. 485 - 495
Main Authors Siegfried, Jill M., Gubish, Christopher T., Rothstein, Mary E., Henry, Cassandra, Stabile, Laura P.
Format Journal Article
LanguageEnglish
Published 01.03.2012
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
1556-1380
DOI:10.1097/JTO.0b013e31824177ea